Evaluation of Clinical Parameters and Symptoms in Healthy Donors for Granulocyte Collection.
10.17945/kjbt.2015.26.2.132
- Author:
Se Na LEE
1
;
Hyewon LEE
;
Hyeon Seok EOM
;
Ji Yeon SOHN
;
Jung Hee KONG
;
Sun Young KONG
Author Information
1. Department of Laboratory Medicine, Center for Diagnostic Oncology, National Cancer Center, Goyang, Korea. ksy@ncc.re.kr
- Publication Type:Original Article
- Keywords:
Granulocyte collection;
Granulocyte-colony-stimulating factor;
Parameter
- MeSH:
Anti-Bacterial Agents;
Blood Cell Count;
Blood Component Removal;
Dexamethasone;
Fatigue;
Granulocyte Colony-Stimulating Factor;
Granulocytes*;
Headache;
Hip;
Humans;
Injections, Subcutaneous;
Knee;
Retrospective Studies;
Sleep Initiation and Maintenance Disorders;
Tissue Donors*
- From:Korean Journal of Blood Transfusion
2015;26(2):132-141
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Donor granulocyte transfusion has been used as a salvage treatment for neutropenic patients with severe infection who did not respond to antibiotics. Here we investigated hematological parameters of granulocyte collection to evaluate its efficacy and safety. METHODS: The clinical data for 92 procedures of granulocyte collection performed on 82 healthy donors from April 2007 to July 2014 at National Cancer Center were reviewed retrospectively. Healthy donors were pre-medicated 12 hours before apheresis with subcutaneous injection of 600 microg of granulocyte-colony stimulating factor (G-CSF) with or without 8 mg of oral dexamethasone. Blood cell counts of donors at the time of pre- and post- granulocyte collection state of donors were investigated and any clinical symptoms and signs were monitored during the procedure. RESULTS: he median age was 29 years old (range, 18~52). The mean of collected granulocyte volume was 230 mL, and the granulocyte yield in apheresis products was 4.90x10(10) (1.46~7.86). Granulocyte yields showed significant correlation with volume of granulocyte collection, total processing volume, pre-WBC count, and pre-ANC. Granulocyte yields of dexamethasone and G-CSF administration were greater than with G-CSF administration alone. Pain (low back, hip, knee, and whole body), insomnia, fatigue, abdominal discomfort, and/or headache occurred in 21% of donors during mobilization. CONCLUSION: Granulocyte mobilization was safe and effective, and is well-tolerable in healthy donors because collection was possible in all donors without complications of G-CSF and dexamethasone administration and apheresis.
